The Effect of Exercise on Migraine Attacks in Chronic Migraine
Primary Purpose
Migraine, Chronic Migraine
Status
Recruiting
Phase
Not Applicable
Locations
Turkey
Study Type
Interventional
Intervention
Combined exercise
Aerobic exercise
Sponsored by
About this trial
This is an interventional supportive care trial for Migraine focused on measuring Headache, Exercise
Eligibility Criteria
Inclusion Criteria:
- A diagnosis of chronic migraine confirmed by a specialist neurologist according to ICHD-3B
- No obstacle to exercise in the evaluation made with physical examination and ECG
- Diagnosed with migraine for at least 12 months
- Between the ages of 18-50
Exclusion Criteria:
- Exercising regularly in the last 6 months
- Presence of concomitant internal and neurological diseases
- Anti-psychotic drug use
- Drug, alcohol addiction
- Pregnancy, breastfeeding
- Patients who cannot reach the targeted exercise level
Sites / Locations
- Ege University Sport Medicine ClinicRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Experimental
Experimental
No Intervention
Arm Label
Combined exercise group
Aerobic exercise group
Control group
Arm Description
Aerobic plus resistance exercise intervention
Only aerobic exercise intervention
Outcomes
Primary Outcome Measures
Change in the number of days with migraine (in migraine frequency)
Defined as the number of days with a migraine headache in a month
Secondary Outcome Measures
Intensity of headache
A categorical, four level rating scale will be used to rate each headache as absent, mild, moderate, or severe
Responder rate
The responder rate is calculated as a percent reduction from baseline in the number of migraine days or number of moderate or severe headache days in each treatment period
Depression and anxiety
Hospital Anxiety and Depression Scale (HADS) will be used. Score could score between 0 and 21 for either anxiety or depression . Higher points are associated with worse anxiety or depression
Migraine specific quality of life
Migraine Disability Assessment (MIDAS) questionnaire will be used . There is no upper limit on scoring. More than 21 points show severe disability. Higher points mean more disability
Aerobic capacity measurement
Astrand submaximal bicycle ergometer test will be used to measure aerobic capacity.
Acute treatment utilization
Change the frequency of use of acute headache medications(which not effect of migraine frequency) during the trial
Change in physical activity level
The International Physical Activity Questionnaires (IPAQ) short form will be used. Scoring is not classical numerical type. For activity type and duration are important for scoring. Higher points means more physical activity
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT05568004
Brief Title
The Effect of Exercise on Migraine Attacks in Chronic Migraine
Official Title
The Effect of Exercise on Migraine Attack Frequency in Chronic Migraine
Study Type
Interventional
2. Study Status
Record Verification Date
June 2023
Overall Recruitment Status
Recruiting
Study Start Date
November 28, 2022 (Actual)
Primary Completion Date
March 2024 (Anticipated)
Study Completion Date
May 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Ege University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to evaluate the effect of different exercise types and combinations on migraine attacks in patients with chronic migraine.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Migraine, Chronic Migraine
Keywords
Headache, Exercise
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Care ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
90 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Combined exercise group
Arm Type
Experimental
Arm Description
Aerobic plus resistance exercise intervention
Arm Title
Aerobic exercise group
Arm Type
Experimental
Arm Description
Only aerobic exercise intervention
Arm Title
Control group
Arm Type
No Intervention
Intervention Type
Behavioral
Intervention Name(s)
Combined exercise
Intervention Description
aerobic plus resistance exercise
Intervention Type
Behavioral
Intervention Name(s)
Aerobic exercise
Intervention Description
Only aerobic exercise
Primary Outcome Measure Information:
Title
Change in the number of days with migraine (in migraine frequency)
Description
Defined as the number of days with a migraine headache in a month
Time Frame
Baseline and Week 12 and Week 20
Secondary Outcome Measure Information:
Title
Intensity of headache
Description
A categorical, four level rating scale will be used to rate each headache as absent, mild, moderate, or severe
Time Frame
Baseline and Week 12 and Week 20
Title
Responder rate
Description
The responder rate is calculated as a percent reduction from baseline in the number of migraine days or number of moderate or severe headache days in each treatment period
Time Frame
Week 12 and 20
Title
Depression and anxiety
Description
Hospital Anxiety and Depression Scale (HADS) will be used. Score could score between 0 and 21 for either anxiety or depression . Higher points are associated with worse anxiety or depression
Time Frame
Baseline and Week 12 and Week 20
Title
Migraine specific quality of life
Description
Migraine Disability Assessment (MIDAS) questionnaire will be used . There is no upper limit on scoring. More than 21 points show severe disability. Higher points mean more disability
Time Frame
Baseline and Week 12 and Week 20
Title
Aerobic capacity measurement
Description
Astrand submaximal bicycle ergometer test will be used to measure aerobic capacity.
Time Frame
Baseline and Week 12 and Week 20
Title
Acute treatment utilization
Description
Change the frequency of use of acute headache medications(which not effect of migraine frequency) during the trial
Time Frame
Baseline and Week 12 and Week 20
Title
Change in physical activity level
Description
The International Physical Activity Questionnaires (IPAQ) short form will be used. Scoring is not classical numerical type. For activity type and duration are important for scoring. Higher points means more physical activity
Time Frame
Baseline and Week 12 and Week 20
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
A diagnosis of chronic migraine confirmed by a specialist neurologist according to ICHD-3B
No obstacle to exercise in the evaluation made with physical examination and ECG
Diagnosed with migraine for at least 12 months
Between the ages of 18-50
Exclusion Criteria:
Exercising regularly in the last 6 months
Presence of concomitant internal and neurological diseases
Anti-psychotic drug use
Drug, alcohol addiction
Pregnancy, breastfeeding
Patients who cannot reach the targeted exercise level
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Yunus Emre Meydanal
Phone
+905068046512
Email
yemremeydanal@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Yunus Emre Meydanal
Organizational Affiliation
Ege University Sport Medicine Clinic
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Seckin Senısık
Organizational Affiliation
Ege University Sport Medicine Clinic
Official's Role
Study Director
Facility Information:
Facility Name
Ege University Sport Medicine Clinic
City
İzmir
State/Province
Bornova
Country
Turkey
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yunus Emre Meydanal
Phone
905068046512
Email
yemremeydanal@gmail.com
First Name & Middle Initial & Last Name & Degree
Seckin Senısık
First Name & Middle Initial & Last Name & Degree
Hadiye Sirin
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
29368949
Citation
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018 Jan;38(1):1-211. doi: 10.1177/0333102417738202. No abstract available.
Results Reference
background
PubMed Identifier
27733282
Citation
GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016 Oct 8;388(10053):1545-1602. doi: 10.1016/S0140-6736(16)31678-6. Erratum In: Lancet. 2017 Jan 7;389(10064):e1.
Results Reference
background
PubMed Identifier
28931491
Citation
GBD 2015 Neurological Disorders Collaborator Group. Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol. 2017 Nov;16(11):877-897. doi: 10.1016/S1474-4422(17)30299-5. Epub 2017 Sep 17.
Results Reference
background
PubMed Identifier
17261680
Citation
Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF; AMPP Advisory Group. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007 Jan 30;68(5):343-9. doi: 10.1212/01.wnl.0000252808.97649.21.
Results Reference
background
PubMed Identifier
22246025
Citation
Ertas M, Baykan B, Orhan EK, Zarifoglu M, Karli N, Saip S, Onal AE, Siva A. One-year prevalence and the impact of migraine and tension-type headache in Turkey: a nationwide home-based study in adults. J Headache Pain. 2012 Mar;13(2):147-57. doi: 10.1007/s10194-011-0414-5. Epub 2012 Jan 14.
Results Reference
background
PubMed Identifier
20100298
Citation
Calhoun AH, Ford S, Millen C, Finkel AG, Truong Y, Nie Y. The prevalence of neck pain in migraine. Headache. 2010 Sep;50(8):1273-7. doi: 10.1111/j.1526-4610.2009.01608.x. Epub 2010 Jan 18.
Results Reference
background
PubMed Identifier
25662743
Citation
Lipton RB, Silberstein SD. Episodic and chronic migraine headache: breaking down barriers to optimal treatment and prevention. Headache. 2015 Mar;55 Suppl 2:103-22; quiz 123-6. doi: 10.1111/head.12505_2.
Results Reference
background
PubMed Identifier
23470015
Citation
Smitherman TA, Burch R, Sheikh H, Loder E. The prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies. Headache. 2013 Mar;53(3):427-36. doi: 10.1111/head.12074. Epub 2013 Mar 7.
Results Reference
background
PubMed Identifier
22830411
Citation
Buse DC, Manack AN, Fanning KM, Serrano D, Reed ML, Turkel CC, Lipton RB. Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study. Headache. 2012 Nov-Dec;52(10):1456-70. doi: 10.1111/j.1526-4610.2012.02223.x. Epub 2012 Jul 25.
Results Reference
background
PubMed Identifier
14612481
Citation
Stewart WF, Ricci JA, Chee E, Morganstein D, Lipton R. Lost productive time and cost due to common pain conditions in the US workforce. JAMA. 2003 Nov 12;290(18):2443-54. doi: 10.1001/jama.290.18.2443.
Results Reference
background
PubMed Identifier
20813784
Citation
Blumenfeld AM, Varon SF, Wilcox TK, Buse DC, Kawata AK, Manack A, Goadsby PJ, Lipton RB. Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). Cephalalgia. 2011 Feb;31(3):301-15. doi: 10.1177/0333102410381145. Epub 2010 Sep 2.
Results Reference
background
PubMed Identifier
11703471
Citation
Lipton RB, Stewart WF, Sawyer J, Edmeads JG. Clinical utility of an instrument assessing migraine disability: the Migraine Disability Assessment (MIDAS) questionnaire. Headache. 2001 Oct;41(9):854-61.
Results Reference
background
PubMed Identifier
16385104
Citation
Lipton RB, Bigal ME, Stewart WF. Clinical trials of acute treatments for migraine including multiple attack studies of pain, disability, and health-related quality of life. Neurology. 2005 Dec 29;65(12 Suppl 4):S50-8. doi: 10.1212/wnl.65.12_suppl_4.s50.
Results Reference
background
PubMed Identifier
20164501
Citation
Buse DC, Manack A, Serrano D, Turkel C, Lipton RB. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry. 2010 Apr;81(4):428-32. doi: 10.1136/jnnp.2009.192492. Epub 2010 Feb 17.
Results Reference
background
PubMed Identifier
18711108
Citation
Bigal ME, Serrano D, Reed M, Lipton RB. Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment. Neurology. 2008 Aug 19;71(8):559-66. doi: 10.1212/01.wnl.0000323925.29520.e7.
Results Reference
background
PubMed Identifier
22644168
Citation
Giannini G, Cevoli S, Sambati L, Cortelli P. Migraine: risk factor and comorbidity. Neurol Sci. 2012 May;33 Suppl 1:S37-41. doi: 10.1007/s10072-012-1029-6.
Results Reference
background
PubMed Identifier
20042889
Citation
Stewart WF, Wood GC, Manack A, Varon SF, Buse DC, Lipton RB. Employment and work impact of chronic migraine and episodic migraine. J Occup Environ Med. 2010 Jan;52(1):8-14. doi: 10.1097/JOM.0b013e3181c1dc56.
Results Reference
background
PubMed Identifier
20865469
Citation
Negro A, D'Alonzo L, Martelletti P. Chronic migraine: comorbidities, risk factors, and rehabilitation. Intern Emerg Med. 2010 Oct;5 Suppl 1:S13-9. doi: 10.1007/s11739-010-0457-7.
Results Reference
background
PubMed Identifier
21188255
Citation
Wang SJ, Chen PK, Fuh JL. Comorbidities of migraine. Front Neurol. 2010 Aug 23;1:16. doi: 10.3389/fneur.2010.00016. eCollection 2010.
Results Reference
background
PubMed Identifier
21210177
Citation
Antonaci F, Nappi G, Galli F, Manzoni GC, Calabresi P, Costa A. Migraine and psychiatric comorbidity: a review of clinical findings. J Headache Pain. 2011 Apr;12(2):115-25. doi: 10.1007/s10194-010-0282-4. Epub 2011 Jan 6.
Results Reference
background
PubMed Identifier
9793713
Citation
Breslau N. Psychiatric comorbidity in migraine. Cephalalgia. 1998 Aug;18 Suppl 22:56-8; discussion 58-61. doi: 10.1177/0333102498018s2210. No abstract available.
Results Reference
background
PubMed Identifier
23007859
Citation
Ashina S, Serrano D, Lipton RB, Maizels M, Manack AN, Turkel CC, Reed ML, Buse DC. Depression and risk of transformation of episodic to chronic migraine. J Headache Pain. 2012 Nov;13(8):615-24. doi: 10.1007/s10194-012-0479-9. Epub 2012 Sep 25.
Results Reference
background
PubMed Identifier
15327811
Citation
McWilliams LA, Goodwin RD, Cox BJ. Depression and anxiety associated with three pain conditions: results from a nationally representative sample. Pain. 2004 Sep;111(1-2):77-83. doi: 10.1016/j.pain.2004.06.002.
Results Reference
background
PubMed Identifier
23331287
Citation
Lucchetti G, Peres MF, Lucchetti AL, Mercante JP, Guendler VZ, Zukerman E. Generalized anxiety disorder, subthreshold anxiety and anxiety symptoms in primary headache. Psychiatry Clin Neurosci. 2013 Jan;67(1):41-9. doi: 10.1111/j.1440-1819.2012.02405.x.
Results Reference
background
PubMed Identifier
22527034
Citation
Chen YC, Tang CH, Ng K, Wang SJ. Comorbidity profiles of chronic migraine sufferers in a national database in Taiwan. J Headache Pain. 2012 Jun;13(4):311-9. doi: 10.1007/s10194-012-0447-4. Epub 2012 Apr 12.
Results Reference
background
PubMed Identifier
19187337
Citation
Queiroz LP, Peres MF, Piovesan EJ, Kowacs F, Ciciarelli MC, Souza JA, Zukerman E. A nationwide population-based study of migraine in Brazil. Cephalalgia. 2009 Jun;29(6):642-9. doi: 10.1111/j.1468-2982.2008.01782.x. Epub 2009 Feb 2.
Results Reference
background
PubMed Identifier
18771495
Citation
Varkey E, Hagen K, Zwart JA, Linde M. Physical activity and headache: results from the Nord-Trondelag Health Study (HUNT). Cephalalgia. 2008 Dec;28(12):1292-7. doi: 10.1111/j.1468-2982.2008.01678.x. Epub 2008 Sep 11.
Results Reference
background
PubMed Identifier
17376107
Citation
Wober C, Brannath W, Schmidt K, Kapitan M, Rudel E, Wessely P, Wober-Bingol C; PAMINA Study Group. Prospective analysis of factors related to migraine attacks: the PAMINA study. Cephalalgia. 2007 Apr;27(4):304-14. doi: 10.1111/j.1468-2982.2007.01279.x.
Results Reference
background
PubMed Identifier
14984230
Citation
Koseoglu E, Akboyraz A, Soyuer A, Ersoy AO. Aerobic exercise and plasma beta endorphin levels in patients with migrainous headache without aura. Cephalalgia. 2003 Dec;23(10):972-6. doi: 10.1046/j.1468-2982.2003.00624.x.
Results Reference
background
PubMed Identifier
18783448
Citation
Varkey E, Cider A, Carlsson J, Linde M. A study to evaluate the feasibility of an aerobic exercise program in patients with migraine. Headache. 2009 Apr;49(4):563-70. doi: 10.1111/j.1526-4610.2008.01231.x. Epub 2008 Sep 9.
Results Reference
background
PubMed Identifier
21890526
Citation
Varkey E, Cider A, Carlsson J, Linde M. Exercise as migraine prophylaxis: a randomized study using relaxation and topiramate as controls. Cephalalgia. 2011 Oct;31(14):1428-38. doi: 10.1177/0333102411419681. Epub 2011 Sep 2.
Results Reference
background
PubMed Identifier
21359421
Citation
Domingues RB, Teixeira AL, Domingues SA. Physical practice is associated with less functional disability in medical students with migraine. Arq Neuropsiquiatr. 2011 Feb;69(1):39-43. doi: 10.1590/s0004-282x2011000100009.
Results Reference
background
PubMed Identifier
29333870
Citation
Kroll LS, Hammarlund CS, Linde M, Gard G, Jensen RH. The effects of aerobic exercise for persons with migraine and co-existing tension-type headache and neck pain. A randomized, controlled, clinical trial. Cephalalgia. 2018 Oct;38(12):1805-1816. doi: 10.1177/0333102417752119. Epub 2018 Jan 15.
Results Reference
background
PubMed Identifier
29161767
Citation
Hanssen H, Minghetti A, Magon S, Rossmeissl A, Rasenack M, Papadopoulou A, Klenk C, Faude O, Zahner L, Sprenger T, Donath L. Effects of different endurance exercise modalities on migraine days and cerebrovascular health in episodic migraineurs: A randomized controlled trial. Scand J Med Sci Sports. 2018 Mar;28(3):1103-1112. doi: 10.1111/sms.13023. Epub 2018 Jan 8.
Results Reference
background
PubMed Identifier
21472632
Citation
Darabaneanu S, Overath CH, Rubin D, Luthje S, Sye W, Niederberger U, Gerber WD, Weisser B. Aerobic exercise as a therapy option for migraine: a pilot study. Int J Sports Med. 2011 Jun;32(6):455-60. doi: 10.1055/s-0030-1269928. Epub 2011 Apr 6.
Results Reference
background
PubMed Identifier
30764753
Citation
Lemmens J, De Pauw J, Van Soom T, Michiels S, Versijpt J, van Breda E, Castien R, De Hertogh W. The effect of aerobic exercise on the number of migraine days, duration and pain intensity in migraine: a systematic literature review and meta-analysis. J Headache Pain. 2019 Feb 14;20(1):16. doi: 10.1186/s10194-019-0961-8.
Results Reference
background
PubMed Identifier
21694556
Citation
Garber CE, Blissmer B, Deschenes MR, Franklin BA, Lamonte MJ, Lee IM, Nieman DC, Swain DP; American College of Sports Medicine. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc. 2011 Jul;43(7):1334-59. doi: 10.1249/MSS.0b013e318213fefb.
Results Reference
background
PubMed Identifier
26643584
Citation
Irby MB, Bond DS, Lipton RB, Nicklas B, Houle TT, Penzien DB. Aerobic Exercise for Reducing Migraine Burden: Mechanisms, Markers, and Models of Change Processes. Headache. 2016 Feb;56(2):357-69. doi: 10.1111/head.12738. Epub 2015 Dec 8.
Results Reference
background
PubMed Identifier
23314782
Citation
Misra UK, Kalita J, Tripathi GM, Bhoi SK. Is beta endorphin related to migraine headache and its relief? Cephalalgia. 2013 Apr;33(5):316-22. doi: 10.1177/0333102412473372. Epub 2013 Jan 11.
Results Reference
background
PubMed Identifier
20188719
Citation
Beavers KM, Brinkley TE, Nicklas BJ. Effect of exercise training on chronic inflammation. Clin Chim Acta. 2010 Jun 3;411(11-12):785-93. doi: 10.1016/j.cca.2010.02.069. Epub 2010 Feb 25.
Results Reference
background
PubMed Identifier
15388533
Citation
Dietrich A, McDaniel WF. Endocannabinoids and exercise. Br J Sports Med. 2004 Oct;38(5):536-41. doi: 10.1136/bjsm.2004.011718.
Results Reference
background
PubMed Identifier
17367586
Citation
Hoffman MD, Hoffman DR. Does aerobic exercise improve pain perception and mood? A review of the evidence related to healthy and chronic pain subjects. Curr Pain Headache Rep. 2007 Apr;11(2):93-7. doi: 10.1007/s11916-007-0004-z.
Results Reference
background
PubMed Identifier
23073072
Citation
Houle TT, Butschek RA, Turner DP, Smitherman TA, Rains JC, Penzien DB. Stress and sleep duration predict headache severity in chronic headache sufferers. Pain. 2012 Dec;153(12):2432-2440. doi: 10.1016/j.pain.2012.08.014. Epub 2012 Oct 13.
Results Reference
background
PubMed Identifier
17501846
Citation
John PJ, Sharma N, Sharma CM, Kankane A. Effectiveness of yoga therapy in the treatment of migraine without aura: a randomized controlled trial. Headache. 2007 May;47(5):654-61. doi: 10.1111/j.1526-4610.2007.00789.x.
Results Reference
background
PubMed Identifier
28854396
Citation
Andersen CH, Jensen RH, Dalager T, Zebis MK, Sjogaard G, Andersen LL. Effect of resistance training on headache symptoms in adults: Secondary analysis of a RCT. Musculoskelet Sci Pract. 2017 Dec;32:38-43. doi: 10.1016/j.msksp.2017.08.003. Epub 2017 Aug 14.
Results Reference
background
PubMed Identifier
22258395
Citation
Sullivan AB, Scheman J, Venesy D, Davin S. The role of exercise and types of exercise in the rehabilitation of chronic pain: specific or nonspecific benefits. Curr Pain Headache Rep. 2012 Apr;16(2):153-61. doi: 10.1007/s11916-012-0245-3.
Results Reference
background
PubMed Identifier
12220386
Citation
Hagen K, Einarsen C, Zwart JA, Svebak S, Bovim G. The co-occurrence of headache and musculoskeletal symptoms amongst 51 050 adults in Norway. Eur J Neurol. 2002 Sep;9(5):527-33. doi: 10.1046/j.1468-1331.2002.00451.x.
Results Reference
background
PubMed Identifier
7154893
Citation
Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14(5):377-81.
Results Reference
background
PubMed Identifier
4721013
Citation
Skinner JS, Hutsler R, Bergsteinova V, Buskirk ER. The validity and reliability of a rating scale of perceived exertion. Med Sci Sports. 1973 Summer;5(2):94-6. No abstract available.
Results Reference
background
PubMed Identifier
10522637
Citation
Lamb KL, Eston RG, Corns D. Reliability of ratings of perceived exertion during progressive treadmill exercise. Br J Sports Med. 1999 Oct;33(5):336-9. doi: 10.1136/bjsm.33.5.336.
Results Reference
background
PubMed Identifier
24511345
Citation
Muyor JM. Exercise Intensity and Validity of the Ratings of Perceived Exertion (Borg and OMNI Scales) in an Indoor Cycling Session. J Hum Kinet. 2013 Dec 31;39:93-101. doi: 10.2478/hukin-2013-0072. eCollection 2013 Dec 18.
Results Reference
background
PubMed Identifier
22210471
Citation
Colado JC, Garcia-Masso X, Triplett TN, Flandez J, Borreani S, Tella V. Concurrent validation of the OMNI-resistance exercise scale of perceived exertion with Thera-band resistance bands. J Strength Cond Res. 2012 Nov;26(11):3018-24. doi: 10.1519/JSC.0b013e318245c0c9.
Results Reference
background
PubMed Identifier
13211501
Citation
ASTRAND PO, RYHMING I. A nomogram for calculation of aerobic capacity (physical fitness) from pulse rate during sub-maximal work. J Appl Physiol. 1954 Sep;7(2):218-21. doi: 10.1152/jappl.1954.7.2.218. No abstract available.
Results Reference
background
Learn more about this trial
The Effect of Exercise on Migraine Attacks in Chronic Migraine
We'll reach out to this number within 24 hrs